Literature DB >> 21448941

7 tesla MRI of microbleeds and white matter lesions as seen in vascular dementia.

Jens M Theysohn1, Oliver Kraff, Stefan Maderwald, Markus Barth, Susanne C Ladd, Michael Forsting, Mark E Ladd, Elke R Gizewski.   

Abstract

PURPOSE: To evaluate 7T MRI in the assessment of cerebrovascular alterations as seen in vascular dementia by means of detection of cerebral microbleeds (CMB) and depiction of white matter lesions (WML). 7T imaging was evaluated with respect to 1.5T.
MATERIALS AND METHODS: Ten healthy volunteers and 10 patients with CMBs and/or WMLs were examined at 1.5T and 7T using gradient-echo (T2*, SWI) and turbo-spin-echo sequences (FLAIR). Comparisons of image quality, CMB and WML detection rates between sequences and field strengths were performed.
RESULTS: Using high-resolution SWI at 7T 129 CMBs were detected compared to 75 at 1.5T using clinical SWI. With T2* at 7T 101 CMBs could be detected (33 CMBs at 1.5T). Lesion sizes were significantly larger for higher field strength. FLAIR images at 7T highlighted WMLs known from 1.5T with comparable extent. Gray and white matter contrast in FLAIR was slightly better at 1.5T, whereas image resolution and contrast of the WMLs to surrounding tissue was higher at 7T.
CONCLUSION: By means of higher sensitivity for CMBs, 7T (SWI, T2*) might have significant impact on the early detection, diagnosis, and optimized antithrombotic therapy of cerebrovascular patients (eg, vascular dementia) in the future. Given the current state of technical development, 7T is approximately on par with 1.5T in the depiction of WMLs and their distribution, but holds the potential for future improvements.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21448941     DOI: 10.1002/jmri.22513

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  18 in total

1.  The Road Ahead to Cure Alzheimer's Disease: Development of Biological Markers and Neuroimaging Methods for Prevention Trials Across all Stages and Target Populations.

Authors:  E Cavedo; S Lista; Z Khachaturian; P Aisen; P Amouyel; K Herholz; C R Jack; R Sperling; J Cummings; K Blennow; S O'Bryant; G B Frisoni; A Khachaturian; M Kivipelto; W Klunk; K Broich; S Andrieu; M Thiebaut de Schotten; J-F Mangin; A A Lammertsma; K Johnson; S Teipel; A Drzezga; A Bokde; O Colliot; H Bakardjian; H Zetterberg; B Dubois; B Vellas; L S Schneider; H Hampel
Journal:  J Prev Alzheimers Dis       Date:  2014-12

Review 2.  Magnetic resonance imaging at ultrahigh fields.

Authors:  Kamil Ugurbil
Journal:  IEEE Trans Biomed Eng       Date:  2014-03-25       Impact factor: 4.538

Review 3.  Perspectives of Ultra-High-Field MRI in Neuroradiology.

Authors:  E R Gizewski; C Mönninghoff; M Forsting
Journal:  Clin Neuroradiol       Date:  2015-07-17       Impact factor: 3.649

Review 4.  New insights into vascular pathology by ultrahigh-field magnetic resonance imaging.

Authors:  Jan Sobesky
Journal:  J Cereb Blood Flow Metab       Date:  2012-12-19       Impact factor: 6.200

Review 5.  Reproducibility and variability of quantitative magnetic resonance imaging markers in cerebral small vessel disease.

Authors:  François De Guio; Eric Jouvent; Geert Jan Biessels; Sandra E Black; Carol Brayne; Christopher Chen; Charlotte Cordonnier; Frank-Eric De Leeuw; Martin Dichgans; Fergus Doubal; Marco Duering; Carole Dufouil; Emrah Duzel; Franz Fazekas; Vladimir Hachinski; M Arfan Ikram; Jennifer Linn; Paul M Matthews; Bernard Mazoyer; Vincent Mok; Bo Norrving; John T O'Brien; Leonardo Pantoni; Stefan Ropele; Perminder Sachdev; Reinhold Schmidt; Sudha Seshadri; Eric E Smith; Luciano A Sposato; Blossom Stephan; Richard H Swartz; Christophe Tzourio; Mark van Buchem; Aad van der Lugt; Robert van Oostenbrugge; Meike W Vernooij; Anand Viswanathan; David Werring; Frank Wollenweber; Joanna M Wardlaw; Hugues Chabriat
Journal:  J Cereb Blood Flow Metab       Date:  2016-05-11       Impact factor: 6.200

Review 6.  High-field imaging of neurodegenerative diseases.

Authors:  M J Versluis; J van der Grond; M A van Buchem; P van Zijl; A G Webb
Journal:  Neuroimaging Clin N Am       Date:  2012-03-31       Impact factor: 2.264

7.  Simultaneous imaging of radiation-induced cerebral microbleeds, arteries and veins, using a multiple gradient echo sequence at 7 Tesla.

Authors:  Wei Bian; Suchandrima Banerjee; Douglas A C Kelly; Christopher P Hess; Peder E Z Larson; Susan M Chang; Sarah J Nelson; Janine M Lupo
Journal:  J Magn Reson Imaging       Date:  2014-12-04       Impact factor: 4.813

8.  Susceptibility-weighted MR imaging of radiation therapy-induced cerebral microbleeds in patients with glioma: a comparison between 3T and 7T.

Authors:  Wei Bian; Christopher P Hess; Susan M Chang; Sarah J Nelson; Janine M Lupo
Journal:  Neuroradiology       Date:  2013-11-27       Impact factor: 2.804

Review 9.  Susceptibility-weighted imaging: current status and future directions.

Authors:  Saifeng Liu; Sagar Buch; Yongsheng Chen; Hyun-Seok Choi; Yongming Dai; Charbel Habib; Jiani Hu; Joon-Yong Jung; Yu Luo; David Utriainen; Meiyun Wang; Dongmei Wu; Shuang Xia; E Mark Haacke
Journal:  NMR Biomed       Date:  2016-05-18       Impact factor: 4.044

10.  Prevalence and topography of small hypointense foci suggesting microbleeds on 3T susceptibility-weighted imaging in various types of dementia.

Authors:  H Uetani; T Hirai; M Hashimoto; M Ikeda; M Kitajima; F Sakamoto; D Utsunomiya; S Oda; S Sugiyama; J Matsubara; Y Yamashita
Journal:  AJNR Am J Neuroradiol       Date:  2012-11-01       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.